Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 51 | $1,308,542 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 08 Jul 2024 17:59 | GTHX | G1 Therapeutics Inc | PERRY ANDREW | Chief Commercial Officer | 05 Jul 2024 | Sale | 1,337 | 2.5077 | 3,353 | D |
| 08 Jul 2024 17:58 | GTHX | G1 Therapeutics Inc | MURDOCK TERRY L | Chief Operating Officer | 05 Jul 2024 | Sale | 2,475 | 2.5077 | 6,207 | D |
| 08 Jul 2024 17:57 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 05 Jul 2024 | Sale | 2,475 | 2.5077 | 6,207 | D |
| 08 Jul 2024 17:55 | GTHX | G1 Therapeutics Inc | AVAGLIANO MARK | Chief Business Officer | 05 Jul 2024 | Sale | 2,638 | 2.5077 | 6,615 | D |
| 08 Jul 2024 17:54 | GTHX | G1 Therapeutics Inc | UMSTEAD JOHN W. V | Chief Financial Officer | 05 Jul 2024 | Sale | 527 | 2.5077 | 1,322 | D |
| 08 Jul 2024 17:53 | GTHX | G1 Therapeutics Inc | BAILEY JOHN E. (JACK) JR. | President and CEO | 05 Jul 2024 | Sale | 7,662 | 2.5077 | 19,214 | D |
| 24 May 2024 16:15 | GTHX | G1 Therapeutics Inc | THOMAS MONICA R. | Chief Legal & People Officer | 23 May 2024 | Sale | 5,826 | 4.2678 | 24,864 | D |
| 15 May 2024 16:12 | GTHX | G1 Therapeutics Inc | PERRY ANDREW | Chief Commercial Officer | 13 May 2024 | Sale | 8,151 | 4.7888 | 39,034 | D |
| 15 May 2024 16:11 | GTHX | G1 Therapeutics Inc | UMSTEAD JOHN W. V | Chief Financial Officer | 13 May 2024 | Sale | 8,151 | 4.7888 | 39,034 | D |
| 15 May 2024 16:10 | GTHX | G1 Therapeutics Inc | MURDOCK TERRY L | Chief Operating Officer | 13 May 2024 | Sale | 8,151 | 4.7888 | 39,034 | D |
| 15 May 2024 16:08 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 13 May 2024 | Sale | 8,151 | 4.7888 | 39,034 | D |
| 15 May 2024 16:07 | GTHX | G1 Therapeutics Inc | AVAGLIANO MARK | Chief Business Officer | 13 May 2024 | Sale | 8,151 | 4.7888 | 39,034 | D |
| 15 May 2024 16:06 | GTHX | G1 Therapeutics Inc | BAILEY JOHN E. (JACK) JR. | President and CEO | 13 May 2024 | Sale | 37,258 | 4.7888 | 178,421 | D |
| 20 Mar 2024 16:32 | GTHX | G1 Therapeutics Inc | UMSTEAD JOHN W. V | Chief Financial Officer | 18 Mar 2024 | Sale | 6,547 | 3.0169 | 19,752 | D |
| 13 Feb 2024 18:14 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 12 Feb 2024 | Sale | 28,600 | 4.6204 | 132,143 | D |
| 08 Jan 2024 06:04 | GTHX | G1 Therapeutics Inc | UMSTEAD JOHN W. V | Chief Financial Officer | 04 Jan 2024 | Sale | 111 | 2.9423 | 327 | D |
| 08 Jan 2024 06:04 | GTHX | G1 Therapeutics Inc | UMSTEAD JOHN W. V | Chief Financial Officer | 03 Jan 2024 | Sale | 253 | 3.1189 | 789 | D |
| 08 Jan 2024 06:04 | GTHX | G1 Therapeutics Inc | UMSTEAD JOHN W. V | Chief Financial Officer | 03 Jan 2024 | Sale | 379 | 3.1189 | 1,182 | D |
| 08 Jan 2024 06:03 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 04 Jan 2024 | Sale | 721 | 2.9423 | 2,121 | D |
| 08 Jan 2024 06:03 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 03 Jan 2024 | Sale | 758 | 3.1189 | 2,364 | D |
| 08 Jan 2024 06:03 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 03 Jan 2024 | Sale | 2,261 | 3.1189 | 7,052 | D |
| 08 Jan 2024 06:03 | GTHX | G1 Therapeutics Inc | PERRY ANDREW | Chief Commercial Officer | 03 Jan 2024 | Sale | 2,034 | 3.1189 | 6,344 | D |
| 08 Jan 2024 06:03 | GTHX | G1 Therapeutics Inc | PERRY ANDREW | Chief Commercial Officer | 03 Jan 2024 | Sale | 379 | 3.1189 | 1,182 | D |
| 08 Jan 2024 06:02 | GTHX | G1 Therapeutics Inc | BAILEY JOHN E. (JACK) JR. | President and CEO | 03 Jan 2024 | Sale | 9,094 | 3.1189 | 28,363 | D |
| 08 Jan 2024 06:02 | GTHX | G1 Therapeutics Inc | BAILEY JOHN E. (JACK) JR. | President and CEO | 03 Jan 2024 | Sale | 2,592 | 3.1189 | 8,084 | D |
| 08 Jan 2024 06:02 | GTHX | G1 Therapeutics Inc | AVAGLIANO MARK | Chief Business Officer | 04 Jan 2024 | Sale | 721 | 2.9423 | 2,121 | D |
| 08 Jan 2024 06:02 | GTHX | G1 Therapeutics Inc | AVAGLIANO MARK | Chief Business Officer | 03 Jan 2024 | Sale | 2,602 | 3.1189 | 8,115 | D |
| 08 Jan 2024 06:02 | GTHX | G1 Therapeutics Inc | AVAGLIANO MARK | Chief Business Officer | 03 Jan 2024 | Sale | 758 | 3.1189 | 2,364 | D |
| 08 Jan 2024 06:00 | GTHX | G1 Therapeutics Inc | MURDOCK TERRY L | Chief Operating Officer | 04 Jan 2024 | Sale | 721 | 2.9423 | 2,121 | D |
| 08 Jan 2024 06:00 | GTHX | G1 Therapeutics Inc | MURDOCK TERRY L | Chief Operating Officer | 03 Jan 2024 | Sale | 2,261 | 3.1189 | 7,052 | D |
| 08 Jan 2024 06:00 | GTHX | G1 Therapeutics Inc | MURDOCK TERRY L | Chief Operating Officer | 03 Jan 2024 | Sale | 758 | 3.1189 | 2,364 | D |
| 02 Jan 2024 19:44 | GTHX | G1 Therapeutics Inc | BAILEY JOHN E. (JACK) JR. | President and CEO | 02 Jan 2024 | Sale | 32,983 | 3.2746 | 108,006 | D |
| 13 Dec 2023 16:45 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 11 Dec 2023 | Sale | 12,400 | 4.0212 | 49,863 | D |
| 13 Dec 2023 16:45 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 11 Dec 2023 | Sale | 21,439 | 3.0626 | 65,659 | D |
| 10 Aug 2023 16:11 | GTHX | G1 Therapeutics Inc | VELLECA MARK A. | Director | 08 Aug 2023 | Sale | 2,714 | 2.02 | 5,482 | D |
| 10 Aug 2023 16:11 | GTHX | G1 Therapeutics Inc | VELLECA MARK A. | Director | 08 Aug 2023 | Sale | 57,286 | 1.9986 | 114,492 | D |
| 07 Jul 2023 16:08 | GTHX | G1 Therapeutics Inc | PERRY ANDREW | Chief Commercial Officer | 05 Jul 2023 | Sale | 355 | 2.4537 | 871 | D |
| 07 Jul 2023 16:08 | GTHX | G1 Therapeutics Inc | MURDOCK TERRY L | Chief Operating Officer | 05 Jul 2023 | Sale | 1,361 | 2.4537 | 3,339 | D |
| 07 Jul 2023 16:08 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 05 Jul 2023 | Sale | 1,361 | 2.4537 | 3,339 | D |
| 07 Jul 2023 16:07 | GTHX | G1 Therapeutics Inc | BAILEY JOHN E. (JACK) JR. | President and CEO | 05 Jul 2023 | Sale | 2,719 | 2.4537 | 6,672 | D |
| 05 Jan 2023 20:26 | GTHX | G1 Therapeutics Inc | MOSES JENNIFER K. | CFO | 05 Jan 2023 | Sale | 729 | 5.4075 | 3,942 | D |
| 05 Jan 2023 20:26 | GTHX | G1 Therapeutics Inc | MOSES JENNIFER K. | CFO | 04 Jan 2023 | Sale | 1,639 | 5.5756 | 9,138 | D |
| 05 Jan 2023 20:26 | GTHX | G1 Therapeutics Inc | MURDOCK TERRY L | Chief Operating Officer | 05 Jan 2023 | Sale | 729 | 5.4075 | 3,942 | D |
| 05 Jan 2023 20:26 | GTHX | G1 Therapeutics Inc | MURDOCK TERRY L | Chief Operating Officer | 04 Jan 2023 | Sale | 1,639 | 5.5756 | 9,138 | D |
| 05 Jan 2023 20:25 | GTHX | G1 Therapeutics Inc | PERRY ANDREW | Chief Commercial Officer | 04 Jan 2023 | Sale | 820 | 5.5756 | 4,572 | D |
| 05 Jan 2023 20:25 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 05 Jan 2023 | Sale | 729 | 5.4075 | 3,942 | D |
| 05 Jan 2023 20:25 | GTHX | G1 Therapeutics Inc | MALIK RAJESH | Chief Medical Officer | 04 Jan 2023 | Sale | 1,639 | 5.5756 | 9,138 | D |
| 05 Jan 2023 20:25 | GTHX | G1 Therapeutics Inc | HANSON JAMES S. | General Counsel | 05 Jan 2023 | Sale | 729 | 5.4075 | 3,942 | D |
| 05 Jan 2023 20:25 | GTHX | G1 Therapeutics Inc | HANSON JAMES S. | General Counsel | 04 Jan 2023 | Sale | 1,639 | 5.5756 | 9,138 | D |
| 05 Jan 2023 20:23 | GTHX | G1 Therapeutics Inc | BAILEY JOHN E. (JACK) JR. | President and CEO | 04 Jan 2023 | Sale | 5,607 | 5.5756 | 31,262 | D |
| 05 Jan 2023 20:23 | GTHX | G1 Therapeutics Inc | BAILEY JOHN E. (JACK) JR. | President and CEO | 03 Jan 2023 | Sale | 32,019 | 5.8544 | 187,452 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)